AU2687992A - Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof - Google Patents

Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof

Info

Publication number
AU2687992A
AU2687992A AU26879/92A AU2687992A AU2687992A AU 2687992 A AU2687992 A AU 2687992A AU 26879/92 A AU26879/92 A AU 26879/92A AU 2687992 A AU2687992 A AU 2687992A AU 2687992 A AU2687992 A AU 2687992A
Authority
AU
Australia
Prior art keywords
antibodies
antigen
specificity
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26879/92A
Inventor
John Ghayreb
Jim Looney
Hiroshi Takahashi
Jack R. Wands
Sven Ole Warnaar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Janssen Biotech Inc
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2687992A publication Critical patent/AU2687992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU26879/92A 1991-09-25 1992-09-25 Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof Abandoned AU2687992A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US765612 1985-08-14
US76535191A 1991-09-25 1991-09-25
US76535091A 1991-09-25 1991-09-25
US76561291A 1991-09-25 1991-09-25
US765350 1991-09-25
US765351 1991-09-25

Publications (1)

Publication Number Publication Date
AU2687992A true AU2687992A (en) 1993-04-27

Family

ID=27419609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26879/92A Abandoned AU2687992A (en) 1991-09-25 1992-09-25 Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof

Country Status (2)

Country Link
AU (1) AU2687992A (en)
WO (1) WO1993006117A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004042401A1 (en) * 2002-11-08 2004-05-21 Hiroshi Takahashi Method of examining cancer cells and reagent therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit

Also Published As

Publication number Publication date
WO1993006117A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
AU6266899A (en) Methods for producing human tumor antigen specific antibodies
AU4589289A (en) Synthetic antigens, a process for the preparation thereof and the use thereof
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
AU1860292A (en) Absorptive materials, and methods for their production
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
EP0599159A3 (en) Alpha-L-rhamnosidase for obtaining rhamnose, process for the preparation and use.
AU2712192A (en) Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof
AU2895489A (en) Gene fragments coding for anti-hiv antibody variable region, anti-hiv chimeric antibody expressed using the same, and process for preparation thereof
AU8271191A (en) Indolonaphthyridines, their production and use
EP0545547A3 (en) Immobilized enzyme film, protein immobilized film and process for forming the same
AU2687992A (en) Sf-25 antibodies, especially chimeric antibodies, with specificity for the human tumor sf-25 antigen, methods for their production, and uses thereof
WO1997013858A3 (en) Baboon mage-3 homologs, dna encoding the homologs, and a process for their use
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU2267188A (en) One-way valve, method for the production thereof and the use of the valve
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto
AU5873094A (en) Multivalent ab1 antibodies as vaccines
EP0582450A3 (en) Anti-oxytocin receptor antibodies and methods for their production.
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
AU1809695A (en) Tumor associated monoclonal antibody 123av16
AU646941B2 (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process